Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR mHealth and uHealth

Date Submitted: May 28, 2019
Open Peer Review Period: May 28, 2019 - Jun 4, 2019
Date Accepted: Jul 19, 2019
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

A Tablet-Based App for Carpal Tunnel Syndrome Screening: Diagnostic Case-Control Study

Fujita K, Watanabe T, Kuroiwa T, Sasaki T, Nimura A, Sugiura Y

A Tablet-Based App for Carpal Tunnel Syndrome Screening: Diagnostic Case-Control Study

JMIR Mhealth Uhealth 2019;7(9):e14172

DOI: 10.2196/14172

PMID: 31586365

PMCID: 6779028

Tablet-based app development for diagnosing carpal tunnel syndrome

  • Koji Fujita; 
  • Takuro Watanabe; 
  • Tomoyuki Kuroiwa; 
  • Toru Sasaki; 
  • Akimoto Nimura; 
  • Yuta Sugiura

ABSTRACT

Background:

Carpal tunnel syndrome (CTS), the most common neuropathy, is caused by a compression of median nerve in the carpal tunnel and is related to aging. The initial symptom is numbness and pain of the median nerve, distributed in the hand area, while thenar muscle atrophy occurs in advanced stages. This atrophy causes failure of thumb motion and results in clumsiness; even after surgery, thenar atrophy does not recover for an extended period. Medical examination and electrophysiological testing are useful to diagnose CTS; however, visits to the doctor tend to be delayed because patients neglect the symptom of numbness in the hand. To avoid thenar atrophy-related clumsiness, early detection of CTS is important.

Objective:

To establish a CTS diagnosis system without medical examination, we have developed a tablet-based CTS detection system, focusing on movement of the thumb in CTS patients and examined the accuracy of this diagnostic system.

Methods:

Twenty-two CTS female patients, involving 29 hands, and 11 non-CTS female participants were recruited. The diagnosis of CTS was made by hand-surgeons, based on electrophysiological testing. We developed an iPad-based app, which recorded the speed and timing of thumb movements while playing a short game. A machine learning algorithm (support vector machine, SVM) was then used, by comparing CTS and non-CTS groups in each direction of thumb movement with leave-one-out cross-validation, to diagnose CTS in real time.

Results:

The maximum speed of thumb movement between CTS and non-CTS groups in each direction did not show any statistically significant difference. The CTS group showed significantly slower average thumb movement speed in the 3 and 6 o’clock directions (P = .03, .005, respectively), and also took significantly longer time to reach the points in the 2, 3, 4, 5, 6, 8, 9, and 11 o’clock directions (P < .05). Cross-validation revealed that 27 CTS patients were diagnosed as having CTS, while 2 CTS patients did not have CTS. CTS and non-CTS individuals were classified correctly in 73% and 93% of cases, respectively.

Conclusions:

Our newly developed app could diagnose disturbance of thumb opposition movement and could be useful as a screening test for CTS patients. Outside of the clinic, this app might be able to detect middle to severe stage CTS and prompt these patients to visit a hand surgery specialist and may lead to medical cost-savings. Clinical Trial: yes


 Citation

Please cite as:

Fujita K, Watanabe T, Kuroiwa T, Sasaki T, Nimura A, Sugiura Y

A Tablet-Based App for Carpal Tunnel Syndrome Screening: Diagnostic Case-Control Study

JMIR Mhealth Uhealth 2019;7(9):e14172

DOI: 10.2196/14172

PMID: 31586365

PMCID: 6779028

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.